A citation-based method for searching scientific literature

Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, Alison M Schram, Helen H Won, Sophie Shifman, Amanda Kulick, Laura Baldino, Eneda Toska, Amaia Arruabarrena-Aristorena, Srushti Kittane, Fan Wu, Yanyan Cai, Sabrina Arena, Benedetta Mussolin, Ram Kannan, Neil Vasan, Alexander N Gorelick, Michael F Berger, Ofra Novoplansky, Sankar Jagadeeshan, Yi Liao, Uwe Rix, Sandra Misale, Barry S Taylor, Alberto Bardelli, Jaclyn F Hechtman, David M Hyman, Moshe Elkabets, Elisa de Stanchina, Chandra S Verma, Andrea Ventura, Alexander Drilon, Maurizio Scaltriti. Cancer Discov 2021
Times Cited: 17



A Vaishnavi, M Capelletti, A T Le, S Kako, M Butaney, D Ercan, S Mahale, K D Davies, D L Aisner, A B Pilling, E M Berge, J Kim, H Sasaki, S Park, G Kryukov, L A Garraway, Peter S Hammerman, J Haas, S W Andrews, D Lipson, P J Stephens, V A Miller, M Varella-Garcia, P A J√§nne, R C Doebele. Nat Med 2013
Times Cited: 402




List of shared articles



Times cited

NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance.
Fangfang Liu, Yuxuan Wei, Huan Zhang, Jizong Jiang, Peng Zhang, Qian Chu. Front Oncol 2022
1


Discovery of Next-Generation Tropomyosin Receptor Kinase Inhibitors for Combating Multiple Resistance Associated with Protein Mutation.
Lin-Sheng Zhuo, Ming-Shu Wang, Feng-Xu Wu, Hong-Chuang Xu, Yi Gong, Zhi-Cheng Yu, Yan-Guang Tian, Chao Pang, Ge-Fei Hao, Wei Huang,[...]. J Med Chem 2021
7

TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults.
Guilherme Harada, Alexander Drilon. Cancer Genet 2022
0

NTRK insights: best practices for pathologists.
Jaclyn F Hechtman. Mod Pathol 2022
8